Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The document cannot be parsed.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

The document's conclusion cannot be provided because the content is not accessible.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.